These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23923968)

  • 1. Impact of locoregional therapy and alpha-fetoprotein on outcomes in transplantation for liver cancer: a UNOS Region 6 pooled analysis--conclusion about locoregional therapy.
    Tchilikidi KY
    Clin Transplant; 2013; 27(4):483. PubMed ID: 23923968
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of locoregional therapy and alpha-fetoprotein on outcomes in transplantation for liver cancer: a UNOS Region 6 pooled analysis.
    Wong LL; Naugler WE; Schwartz J; Scott DL; Bhattacharya R; Reyes J; Orloff SL
    Clin Transplant; 2013; 27(1):E72-9. PubMed ID: 23278701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the posttransplant prognosis of patients with hepatocellular carcinoma: what lies beneath alpha-fetoprotein?
    Giannini EG; Savarino V
    Liver Transpl; 2013 Oct; 19(10):1166-7. PubMed ID: 23929508
    [No Abstract]   [Full Text] [Related]  

  • 4. Alpha-fetoprotein and modified response evaluation criteria in solid tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation.
    Lai Q; Avolio AW; Graziadei I; Otto G; Rossi M; Tisone G; Goffette P; Vogel W; Pitton MB; Lerut J;
    Liver Transpl; 2013 Oct; 19(10):1108-18. PubMed ID: 23873764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of bridge therapy prior to orthotopic liver transplantation.
    Prasad MA; Kulik LM
    J Natl Compr Canc Netw; 2014 Aug; 12(8):1183-90; quiz 1191. PubMed ID: 25099448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence of hepatocellular carcinoma after liver transplantation: an update.
    Mazzola A; Costantino A; Petta S; Bartolotta TV; Raineri M; Sacco R; Brancatelli G; Cammà C; Cabibbo G
    Future Oncol; 2015; 11(21):2923-36. PubMed ID: 26414336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiological response and inflammation scores predict tumour recurrence in patients treated with transarterial chemoembolization before liver transplantation.
    Nicolini D; Agostini A; Montalti R; Mocchegiani F; Mincarelli C; Mandolesi A; Robertson NL; Candelari R; Giovagnoni A; Vivarelli M
    World J Gastroenterol; 2017 May; 23(20):3690-3701. PubMed ID: 28611522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional tumor volume and serum alpha-fetoprotein are predictors of hepatocellular carcinoma recurrence after liver transplantation: refined selection criteria.
    Kashkoush S; El Moghazy W; Kawahara T; Gala-Lopez B; Toso C; Kneteman NM
    Clin Transplant; 2014 Jun; 28(6):728-36. PubMed ID: 24708263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
    Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
    J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locoregional therapy and recurrence of hepatocellular carcinoma after liver transplant.
    Kırnap M; Boyvat F; Akdur A; Karakayalı F; Arslan G; Moray G; Haberal M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():166-9. PubMed ID: 24635819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards more effective liver allocation criteria for hepatocellular carcinoma: tumor response to locoregional therapy.
    Lin Y; Chapman WC
    Ann Surg Oncol; 2011 Sep; 18(9):2416-8. PubMed ID: 21590451
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor size remains key for prediction of hepatocellular carcinoma recurrence after liver transplantation.
    Earl TM; Chapman WC
    Ann Surg Oncol; 2011 May; 18(5):1217-8. PubMed ID: 21327456
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hepatocellular carcinoma - diagnosis and treatment].
    Greten TF; Manns MP
    Dtsch Med Wochenschr; 2008 Sep; 133(38):1907-10. PubMed ID: 18785082
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of allogenic hematopoietic stem cell transplantation on tumor recurrence and metastasis of hepatocellular carcinoma after hepatectomy and the relationship with presence of AFP mRNA and VEGF-C mRNA in peripheral blood].
    Deng ZG; Li B; Zu C
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Mar; 41(2):256-60. PubMed ID: 20506647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Fetoprotein and hepatocellular cancer recurrence: a paradigm of the chaos theory.
    Lai Q; Lerut J;
    Liver Transpl; 2014 Oct; 20(10):1283. PubMed ID: 25060782
    [No Abstract]   [Full Text] [Related]  

  • 16. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma.
    Kilickap S; Arslan C; Senel S; Ataseven H
    J Clin Oncol; 2010 Feb; 28(6):e99; author reply e100. PubMed ID: 20085931
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnostic value of alpha-1-fetoprotein (AFP) as a biomarker for hepatocellular carcinoma recurrence after liver transplantation.
    Nörthen A; Asendorf T; Walson PD; Oellerich M
    Clin Biochem; 2018 Feb; 52():20-25. PubMed ID: 29054441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor biology and pre-transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantation.
    Kim PT; Onaca N; Chinnakotla S; Davis GL; Jennings LW; McKenna GJ; Ruiz RM; Levy MF; Goldstein R; Klintmalm GB
    Clin Transplant; 2013; 27(2):311-8. PubMed ID: 23351129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation.
    Heckman JT; Devera MB; Marsh JW; Fontes P; Amesur NB; Holloway SE; Nalesnik M; Geller DA; Steel JL; Gamblin TC
    Ann Surg Oncol; 2008 Nov; 15(11):3169-77. PubMed ID: 18696158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.